Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587171 · ClinicalTrials.gov registry record · Phase 3
Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Terminated
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
NCT00587171 is a Phase 3 study that was terminated before completion, run by Jaeb Center for Health Research. The registered enrollment target is 19 participants.
The verdict
NCT00587171, a Phase 3 study, was terminated before completion, sponsored by Jaeb Center for Health Research.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study is comparing the effectiveness of patching combined with active vision therapy plus near activities versus patching combined with control vision therapy plus near activities for moderate amblyopia (20/40-20/100) in 7 to \<13 year olds. The primary outcome measure is the proportion of patients with visual acuity of 20/25 or better in the amblyopic eye at the 17-week masked exam. These patients will be considered treatment responders. The primary analysis will consist of a comparison between the 2 treatment groups of the proportion of treatment responders with adjustment for baseline visual acuity. Secondary outcomes are stereoacuity at the 17-week masked exam, mean improvement in visual acuity at the 17-week masked exam, and rate of improvement of visual acuity.
Interventions
- DEVICE Patching
- PROCEDURE Near activities
- PROCEDURE Active vision therapy
- PROCEDURE Control vision therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587171
The ClinicalTrials.gov registry entry for NCT00587171 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Patching is the first listed.
NCT00587171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587171 about?
NCT00587171 is a clinical study titled "Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia". This study is comparing the effectiveness of patching combined with active vision therapy plus near activities versus patching combined with control vision therapy plus near activities for moderate amblyopia (20/40-20/100) in 7 to \<13 year olds. The primary outcome measure is the proportion of pat...
What is the current status of trial NCT00587171?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2008-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00587171?
The interventions under investigation include: Patching (DEVICE), Near activities (PROCEDURE), Active vision therapy (PROCEDURE), Control vision therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00587171?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.